ImmuCell Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICCC research report →
Companyimmucell.com
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus.
- CEO
- F. Olivier Te Boekhorst
- IPO
- 1987
- Employees
- 69
- HQ
- Portland, ME, US
Price Chart
Valuation
- Market Cap
- $89.38M
- P/E
- -163.87
- P/S
- 2.99
- P/B
- 3.07
- EV/EBITDA
- 41.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 42.59%
- Op Margin
- 8.35%
- Net Margin
- -1.82%
- ROE
- -1.88%
- ROIC
- 5.97%
Growth & Income
- Revenue
- $27.64M · 4.34%
- Net Income
- $-1,040,027 · 51.78%
- EPS
- $-0.12 · 53.85%
- Op Income
- $1.65M
- FCF YoY
- 1236.00%
Performance & Tape
- 52W High
- $10.25
- 52W Low
- $4.52
- 50D MA
- $7.55
- 200D MA
- $6.48
- Beta
- 0.50
- Avg Volume
- 22.30K
Get TickerSpark's AI analysis on ICCC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 15, 26 | DiMarco Anthony | other | 17,899 |
| Apr 15, 26 | Guillemette Gilles | other | 17,899 |
| Apr 15, 26 | Turner Kathy V | other | 17,899 |
| Apr 15, 26 | Tomsche David Scott | other | 11,933 |
| Apr 15, 26 | Basse Gloria F | other | 11,933 |
| Apr 15, 26 | Wainman Paul R | other | 11,933 |
| Apr 16, 25 | Gathagan Bryan K. | other | 10,000 |
| Apr 16, 25 | Wainman Paul R | other | 10,000 |
| Apr 16, 25 | Tomsche David Scott | other | 10,000 |
| Apr 16, 25 | Brockmann Bobbi Jo | other | 5,000 |
Our ICCC Coverage
We haven't published any research on ICCC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ICCC Report →